BBS-Bioactive Bone Substitutes Oyj (BONEH) - Total Liabilities

Latest as of June 2024: €5.58 Million EUR ≈ $6.52 Million USD

Based on the latest financial reports, BBS-Bioactive Bone Substitutes Oyj (BONEH) has total liabilities worth €5.58 Million EUR (≈ $6.52 Million USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore BBS-Bioactive Bone Substitutes Oyj (BONEH) cash conversion ratio to assess how effectively this company generates cash.

BBS-Bioactive Bone Substitutes Oyj - Total Liabilities Trend (2014–2023)

This chart illustrates how BBS-Bioactive Bone Substitutes Oyj's total liabilities have evolved over time, based on quarterly financial data. Check BONEH financial resilience to evaluate the company's liquid asset resilience ratio.

BBS-Bioactive Bone Substitutes Oyj Competitors by Total Liabilities

The table below lists competitors of BBS-Bioactive Bone Substitutes Oyj ranked by their total liabilities.

Company	Country	Total Liabilities
Yida China Holdings Ltd STU:YC2	Germany	€27.26 Billion
Montanaro UK Smaller Companies Investment Trust PLC LSE:MTU	UK	GBX13.84 Million
BioRestorative Therapies Inc NASDAQ:BRTX	USA	$3.44 Million
Fsport AB ST:FSPORT	Sweden	Skr1.22 Million
WILDCAT PRETR.LS -000028 F:8Y6	Germany	€54.00K
Eurotex Industries and Exports Limited NSE:EUROTEXIND	India	Rs582.50 Million
Scheerders van Kerchove's Verenigde fabrieken nv BR:SCHD	Belgium	€28.75 Million
Eagle Eye Solutions Group plc LSE:EYE	UK	GBX19.35 Million

Liability Composition Analysis (2014–2023)

This chart breaks down BBS-Bioactive Bone Substitutes Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BBS-Bioactive Bone Substitutes Oyj stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.47	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BBS-Bioactive Bone Substitutes Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BBS-Bioactive Bone Substitutes Oyj (2014–2023)

The table below shows the annual total liabilities of BBS-Bioactive Bone Substitutes Oyj from 2014 to 2023.

Year	Total Liabilities	Change
2023-12-31	€5.50 Million ≈ $6.44 Million	-14.21%
2022-12-31	€6.42 Million ≈ $7.50 Million	-6.63%
2021-12-31	€6.87 Million ≈ $8.03 Million	+4.04%
2020-12-31	€6.61 Million ≈ $7.72 Million	-2.19%
2019-12-31	€6.75 Million ≈ $7.90 Million	+0.21%
2018-12-31	€6.74 Million ≈ $7.88 Million	-21.63%
2017-12-31	€8.60 Million ≈ $10.05 Million	+4.80%
2016-12-31	€8.21 Million ≈ $9.59 Million	+2.70%
2015-12-31	€7.99 Million ≈ $9.34 Million	+9.60%
2014-12-31	€7.29 Million ≈ $8.52 Million	--

About BBS-Bioactive Bone Substitutes Oyj

HE:BONEH Finland Medical Devices

Market Cap

$1.76 Million

€1.50 Million EUR

Market Cap Rank

#30127 Global

#150 in Finland

Share Price

€0.05

Change (1 day)

+0.00%

52-Week Range

€0.05 - €0.05

All Time High

€9.68